BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14764070)

  • 1. Protein kinase C and extracellular signal regulated kinase are involved in cardiac hypertrophy of rats with progressive renal injury.
    Takahashi H; Takeishi Y; Miyamoto T; Shishido T; Arimoto T; Konta T; Miyashita T; Ito M; Kubota I
    Eur J Clin Invest; 2004 Feb; 34(2):85-93. PubMed ID: 14764070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
    Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
    Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats.
    Izumi Y; Kim S; Zhan Y; Namba M; Yasumoto H; Iwao H
    Hypertension; 2000 Oct; 36(4):511-6. PubMed ID: 11040228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
    Aoki H; Richmond M; Izumo S; Sadoshima J
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
    Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
    Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.
    Nishiyama A; Yoshizumi M; Rahman M; Kobori H; Seth DM; Miyatake A; Zhang GX; Yao L; Hitomi H; Shokoji T; Kiyomoto H; Kimura S; Tamaki T; Kohno M; Abe Y
    Kidney Int; 2004 Mar; 65(3):972-81. PubMed ID: 14871417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitavastatin inhibits cardiac hypertrophy in a rat model of progressive renal injury.
    Takahashi H; Takeishi Y; Arimoto T; Shishido T; Konta T; Koyama Y; Niizeki T; Kubota I
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):487-93. PubMed ID: 16160602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.
    Takeishi Y; Huang Q; Abe J; Glassman M; Che W; Lee JD; Kawakatsu H; Lawrence EG; Hoit BD; Berk BC; Walsh RA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1637-48. PubMed ID: 11549343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKC mediates cyclic stretch-induced cardiac hypertrophy through Rho family GTPases and mitogen-activated protein kinases in cardiomyocytes.
    Pan J; Singh US; Takahashi T; Oka Y; Palm-Leis A; Herbelin BS; Baker KM
    J Cell Physiol; 2005 Feb; 202(2):536-53. PubMed ID: 15316932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways.
    De Windt LJ; Lim HW; Haq S; Force T; Molkentin JD
    J Biol Chem; 2000 May; 275(18):13571-9. PubMed ID: 10788473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension.
    Yano M; Kim S; Izumi Y; Yamanaka S; Iwao H
    Circ Res; 1998 Oct; 83(7):752-60. PubMed ID: 9758646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta.
    Inagaki K; Iwanaga Y; Sarai N; Onozawa Y; Takenaka H; Mochly-Rosen D; Kihara Y
    J Mol Cell Cardiol; 2002 Oct; 34(10):1377-85. PubMed ID: 12392998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice.
    Pellieux C; Sauthier T; Aubert JF; Brunner HR; Pedrazzini T
    J Hypertens; 2000 Sep; 18(9):1307-17. PubMed ID: 10994762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy.
    Huang CY; Lee FL; Peng SF; Lin KH; Chen RJ; Ho TJ; Tsai FJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2018 Feb; 233(2):979-989. PubMed ID: 28383811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac hypertrophy in the Prague-hypertensive rat is associated with enhanced JNK2 but not ERK tissue activity.
    Vogel V; Bokemeyer D; Heller J; Kramer HJ
    Kidney Blood Press Res; 2001; 24(1):52-6. PubMed ID: 11174007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
    de Boer RA; Pokharel S; Flesch M; van Kampen DA; Suurmeijer AJ; Boomsma F; van Gilst WH; van Veldhuisen DJ; Pinto YM
    J Mol Med (Berl); 2004 Oct; 82(10):678-87. PubMed ID: 15322702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats.
    Touyz RM; He G; El Mabrouk M; Diep Q; Mardigyan V; Schiffrin EL
    J Hypertens; 2001 Mar; 19(3 Pt 2):553-9. PubMed ID: 11327629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy.
    Takahashi T; Konta T; Takasaki S; Ichikawa K; Takeishi Y; Kubota I
    Clin Exp Nephrol; 2007 Sep; 11(3):202-208. PubMed ID: 17891346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.
    Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S
    J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.